High Througput Screening Market to 2025 – Key Player Analysis: Danaher, PerkinElmer, Axxam S.p.A., Tecan Trading AG, Bio-Rad Laboratories, Corning Incorporated, Aurora Biomed

High Througput Screening Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The market of high throughput screening is anticipated to grow with a significant rate in the coming years, owing to factors such as, growth in adoption of globalized innovative models in pharmaceutical and biotechnology companies, increasing investment in research and development, and technological advancement. Moreover, rising prevalence of a number of diseases, and increase in government funding and venture capital investments are also expected to propel the growth of this market. On other hand the rapid growth in emerging countries and growing R&D activities on toxicology and stem cells is expected to offer growth opportunities for the players operating in the high throughput screening market.

Key Players influencing the market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Danaher, PerkinElmer Inc., Axxam S.p.A., Tecan Trading AG, Bio-Rad Laboratories, Inc., Corning Incorporated, Aurora Biomed Inc., and Merck KGaA among others.

Get High Througput Screening Market report sample @ https://www.theinsightpartners.com/sample/TIPBT00002085

High throughput screening (HTS) is majorly used by pharmaceuticals, biotech and academic institutes for drug discovery, target validation and the identification of genes or proteins that modulate a particular biological pathway. High-throughput screening provides efficient measurement of the effects of agents or conditions in biological or chemical assays.

The global high throughput screening market is segmented on the basis of product, technology, application, end user, and geography. The product segment includes, consumables & accessories, reagents & assay kits, services, software, and instruments. On the basis of technology, the high throughput screening market is segmented into cell-based assays, bioinformatics, lab-on-a-chip, label-free technology, and ultra-high-throughput screening. The segment of cell-based assays is further classified into perfusion cell culture, 2D cell culture, and 3D cell culture. On the basis of 3D cell culture, the high throughput screening market is segmented as, scaffold-based technology, and scaffold-free technology. Based on application, the market is segmented into primary and secondary screening, target identification and validation, toxicology assessment, and other applications. Based on end user, the market is classified as, pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and government institutes, and other end users.

The high throughput screening market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global high throughput screening market based on product, technology, and application, and end user. It also provides market size and forecast till 2025 for overall high throughput screening market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The high throughput screening market market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America hold the largest market share of the high throughput screening market, owing to the well developed and established healthcare industry, increased awareness, presence of government initiatives and funding, and easy accessibility to advanced technologies in the region. On the other hand, the Asia-Pacific region is expected to grow at a significant rate during the forecast period. The highest growth in the region is attributed to the increasing research and development activities, and growing demand for better quality medical care in countries such as Japan, China, and India.

Get 20% Discount on Purchase Till 10 Jan 2019 – https://www.theinsightpartners.com/discount/TIPBT00002085

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

Contact us -

Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : [email protected]

Posted by Sameer Joshi on Friday December 28 2018, 4:19 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0